Pfizer Inc. insider trading
In the last twelve months insiders at Pfizer Inc. filed 2 open-market sales worth $134,661 and 3 open-market purchases worth $3.0 million, on Form 4 with the SEC. The latest: Bourla Albert, Chairman & CEO, bought 38,000 shares at $26.34 on 12 August 2026, filed 12 August 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 12 August 2026 | Bourla Albert | Chairman & CEO | Purchase | 38,000 | $26.34 | $1.0 million | Form 4 |
| 5 August 2026 | Damico Jennifer B. | SVP & Controller | Sale | 3,278 | $25.40 | $83,261 | Form 4 |
| 5 August 2026 | Blaylock Ronald E | Director | Purchase | 39,231 | $25.46 | $998,821 | Form 4 |
| 5 August 2026 | Buckley Mortimer J | Director | Purchase | 37,632 | $25.52 | $960,369 | Form 4 |
| 9 June 2026 | Damico Jennifer B. | SVP & Controller | Sale | 2,000 | $25.70 | $51,400 | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Pfizer Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.